Shanghai ZJ Bio-Tech Co (SHSE:688317) Total Liabilities : ¥249.3 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai ZJ Bio-Tech Co Total Liabilities?

Shanghai ZJ Bio-Tech Co's Total Liabilities for the quarter that ended in Dec. 2023 was ¥249.3 Mil.

Shanghai ZJ Bio-Tech Co's quarterly Total Liabilities declined from Jun. 2023 (¥279.52 Mil) to Sep. 2023 (¥227.59 Mil) but then increased from Sep. 2023 (¥227.59 Mil) to Dec. 2023 (¥249.25 Mil).

Shanghai ZJ Bio-Tech Co's annual Total Liabilities increased from Dec. 2021 (¥427.27 Mil) to Dec. 2022 (¥543.44 Mil) but then declined from Dec. 2022 (¥543.44 Mil) to Dec. 2023 (¥249.25 Mil).

Shanghai ZJ Bio-Tech Co Total Liabilities Historical Data

The historical data trend for Shanghai ZJ Bio-Tech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai ZJ Bio-Tech Co Total Liabilities Chart

Shanghai ZJ Bio-Tech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

70.09

416.97

427.27

543.44

249.25

Shanghai ZJ Bio-Tech Co Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															543.44	320.57	279.52	227.59	249.25

Shanghai ZJ Bio-Tech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shanghai ZJ Bio-Tech Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	236.563	+	(4.644	+	8.047
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	249.3

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	4074.191	-	3824.937
	=	249.3

Shanghai ZJ Bio-Tech Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	236.563	+	(4.644	+	8.047
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	249.3

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	4074.191	-	3824.937
	=	249.3

Shanghai ZJ Bio-Tech Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shanghai ZJ Bio-Tech Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai ZJ Bio-Tech Co (SHSE:688317) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai ZJ Bio-Tech Co Ltd (SHSE:688317) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 588 Xinjun Ring Road, Building 26, Pujiang Hi-Tech Park, Caohejing Development Zone, Shanghai, CHN

Website

https://www.liferiver.com.cn

Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.

Shanghai ZJ Bio-Tech Co (SHSE:688317) Headlines

No Headlines